SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology (original) (raw)

• Yokoyama, C. et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75, 187–197 (1993).
  CAS PubMed Google Scholar
• Brown, M. S. & Goldstein, J. L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331–340 (1997).
  CAS PubMed Google Scholar
• Goldstein, J. L., DeBose-Boyd, R. A. & Brown, M. S. Protein sensors for membrane sterols. Cell 124, 35–46 (2006).
  CAS PubMed Google Scholar
• Tontonoz, P., Kim, J. B., Graves, R. A. & Spiegelman, B. M. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13, 4753–4759 (1993).
  CAS PubMed PubMed Central Google Scholar
• Jeon, T. I. & Osborne, T. F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 23, 65–72 (2012).
  CAS PubMed Google Scholar
• Shao, W. & Espenshade, P. J. Expanding roles for SREBP in metabolism. Cell Metab. 16, 414–419 (2012).
  CAS PubMed PubMed Central Google Scholar
• Walker, A. K. et al. A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell 147, 840–852 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hughes, A. L., Todd, B. L. & Espenshade, P. J. SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell 120, 831–842 (2005).
  CAS PubMed Google Scholar
• Im, S. S. et al. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 13, 540–549 (2011).
  CAS PubMed PubMed Central Google Scholar
• Shimano, H. et al. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99, 846–854 (1997).
  CAS PubMed PubMed Central Google Scholar
• Toth, J. I., Datta, S., Athanikar, J. N., Freedman, L. P. & Osborne, T. F. Selective coactivator interactions in gene activation by SREBP-1a and -1c. Mol. Cell. Biol. 24, 8288–8300 (2004).
  CAS PubMed PubMed Central Google Scholar
• Shimano, H. et al. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98, 1575–1584 (1996).
  CAS PubMed PubMed Central Google Scholar
• Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125–1131 (2002).
  CAS PubMed PubMed Central Google Scholar
• Amemiya-Kudo, M. et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J. Lipid Res. 43, 1220–1235 (2002).
  CAS PubMed Google Scholar
• Oliner, J. D., Andresen, J. M., Hansen, S. K., Zhou, S. & Tjian, R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. 10, 2903–2911 (1996).
  CAS PubMed Google Scholar
• Yang, F. et al. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 442, 700–704 (2006).
  CAS PubMed Google Scholar
• Gong, X. et al. Structure of the WD40 domain of SCAP from fission yeast reveals the molecular basis for SREBP recognition. Cell Res. 25, 401–411 (2015).
  CAS PubMed PubMed Central Google Scholar
• Rawson, R. B., DeBose-Boyd, R., Goldstein, J. L. & Brown, M. S. Failure to cleave sterol regulatory element-binding proteins (SREBPs) causes cholesterol auxotrophy in Chinese hamster ovary cells with genetic absence of SREBP cleavage-activating protein. J. Biol. Chem. 274, 28549–28556 (1999).
  CAS PubMed Google Scholar
• Kuan, Y. C. et al. Heat shock protein 90 modulates lipid homeostasis by regulating the stability and function of sterol regulatory element-binding protein (SREBP) and SREBP cleavage-activating protein. J. Biol. Chem. 292, 3016–3028 (2017).
  CAS PubMed Google Scholar
• Sun, L. P., Li, L., Goldstein, J. L. & Brown, M. S. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J. Biol. Chem. 280, 26483–26490 (2005).
  CAS PubMed Google Scholar
• Zhang, Y. et al. Direct demonstration that loop1 of Scap binds to loop7: a crucial event in cholesterol homeostasis. J. Biol. Chem. 291, 12888–12896 (2016).
  CAS PubMed PubMed Central Google Scholar
• Yang, T. et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489–500 (2002).
  CAS PubMed Google Scholar
• Yabe, D., Brown, M. S. & Goldstein, J. L. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc. Natl Acad. Sci. USA 99, 12753–12758 (2002).
  CAS PubMed PubMed Central Google Scholar
• Nakakuki, M. et al. A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid. J. Biochem. 155, 301–313 (2014).
  CAS PubMed Google Scholar
• Takashima, K. et al. COPI-mediated retrieval of SCAP is crucial for regulating lipogenesis under basal and sterol-deficient conditions. J. Cell Sci. 128, 2805–2815 (2015).
  CAS PubMed Google Scholar
• Xu, D. et al. PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus. Nat. Commun. 6, 8100 (2015).
  CAS PubMed Google Scholar
• Mohn, K. L. et al. The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol. Cell. Biol. 11, 381–390 (1991).
  CAS PubMed PubMed Central Google Scholar
• Diamond, R. H. et al. Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing. J. Biol. Chem. 268, 15185–15192 (1993).
  CAS PubMed Google Scholar
• Radhakrishnan, A., Ikeda, Y., Kwon, H. J., Brown, M. S. & Goldstein, J. L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl Acad. Sci. USA 104, 6511–6518 (2007).
  CAS PubMed PubMed Central Google Scholar
• Ren, R. et al. Protein structure. Crystal structure of a mycobacterial Insig homolog provides insight into how these sensors monitor sterol levels. Science 349, 187–191 (2015).
  CAS PubMed PubMed Central Google Scholar
• Jo, Y., Lee, P. C., Sguigna, P. V. & DeBose-Boyd, R. A. Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8. Proc. Natl Acad. Sci. USA 108, 20503–20508 (2011).
  CAS PubMed PubMed Central Google Scholar
• Gong, Y. et al. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab. 3, 15–24 (2006).
  CAS PubMed Google Scholar
• Liu, T. F. et al. Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis. Cell Metab. 16, 213–225 (2012).
  CAS PubMed Google Scholar
• Yabe, D., Komuro, R., Liang, G., Goldstein, J. L. & Brown, M. S. Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc. Natl Acad. Sci. USA 100, 3155–3160 (2003).
  CAS PubMed PubMed Central Google Scholar
• Engelking, L. J. et al. Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin. J. Clin. Invest. 116, 2356–2365 (2006).
  CAS PubMed PubMed Central Google Scholar
• Okada, T. et al. A serine protease inhibitor prevents endoplasmic reticulum stress-induced cleavage but not transport of the membrane-bound transcription factor ATF6. J. Biol. Chem. 278, 31024–31032 (2003).
  CAS PubMed Google Scholar
• Ye, J., Dave, U. P., Grishin, N. V., Goldstein, J. L. & Brown, M. S. Asparagine-proline sequence within membrane-spanning segment of SREBP triggers intramembrane cleavage by site-2 protease. Proc. Natl Acad. Sci. USA 97, 5123–5128 (2000).
  CAS PubMed PubMed Central Google Scholar
• Ye, J. et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell 6, 1355–1364 (2000).
  CAS PubMed Google Scholar
• Hannah, V. C., Ou, J., Luong, A., Goldstein, J. L. & Brown, M. S. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 276, 4365–4372 (2001).
  CAS PubMed Google Scholar
• Lee, J. N., Zhang, X., Feramisco, J. D., Gong, Y. & Ye, J. Unsaturated fatty acids inhibit proteasomal degradation of Insig-1 at a postubiquitination step. J. Biol. Chem. 283, 33772–33783 (2008).
  CAS PubMed PubMed Central Google Scholar
• Lee, J. N. et al. Identification of Ubxd8 protein as a sensor for unsaturated fatty acids and regulator of triglyceride synthesis. Proc. Natl Acad. Sci. USA 107, 21424–21429 (2010).
  CAS PubMed PubMed Central Google Scholar
• Morioka, S. et al. TAK1 regulates hepatic lipid homeostasis through SREBP. Oncogene 35, 3829–3838 (2016).
  CAS PubMed PubMed Central Google Scholar
• Aylon, Y. et al. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. Genes Dev. 30, 786–797 (2016).
  CAS PubMed PubMed Central Google Scholar
• Suchanek, M., Radzikowska, A. & Thiele, C. Photo-leucine and photo-methionine allow identification of protein–protein interactions in living cells. Nat. Methods 2, 261–267 (2005).
  CAS PubMed Google Scholar
• Wang, Q. et al. The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity 41, 919–933 (2014).
  CAS PubMed Google Scholar
• Cai, H. L. et al. A potential mechanism underlying atypical antipsychotics-induced lipid disturbances. Transl Psychiatry 5, e661 (2015).
  CAS PubMed PubMed Central Google Scholar
• Kabe, Y. et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat. Commun. 7, 11030 (2016).
  CAS PubMed PubMed Central Google Scholar
• Hughes, A. L. et al. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab. 5, 143–149 (2007).
  CAS PubMed Google Scholar
• Chen, Y. et al. Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms. Sci. Rep. 4, 7242 (2014).
  CAS PubMed PubMed Central Google Scholar
• Civra, A. et al. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci. Rep. 4, 7487 (2014).
  CAS PubMed PubMed Central Google Scholar
• Cyster, J. G., Dang, E. V., Reboldi, A. & Yi, T. 25-hydroxycholesterols in innate and adaptive immunity. Nat. Rev. Immunol. 14, 731–743 (2014).
  CAS PubMed Google Scholar
• Reboldi, A. et al. Inflammation. 25-hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345, 679–684 (2014).
  CAS PubMed PubMed Central Google Scholar
• Bowie, A. The STING in the tail for cytosolic DNA-dependent activation of IRF3. Sci. Signal. 5, pe9 (2012).
  PubMed Google Scholar
• Chen, W. et al. ER adaptor SCAP translocates and recruits IRF3 to perinuclear microsome induced by cytosolic microbial DNAs. PLoS Pathog. 12, e1005462 (2016).
  PubMed PubMed Central Google Scholar
• Honda, A. et al. Cholesterol 25-hydroxylation activity of CYP3A. J. Lipid Res. 52, 1509–1516 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hashimoto, M. et al. Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver. J. Lipid Res. 54, 2060–2068 (2013).
  CAS PubMed PubMed Central Google Scholar
• Nagoshi, E., Imamoto, N., Sato, R. & Yoneda, Y. Nuclear import of sterol regulatory element-binding protein-2, a basic helix-loop-helix-leucine zipper (bHLH-Zip)-containing transcription factor, occurs through the direct interaction of importin β with HLH-Zip. Mol. Biol. Cell 10, 2221–2233 (1999).
  CAS PubMed PubMed Central Google Scholar
• Nagoshi, E. & Yoneda, Y. Dimerization of sterol regulatory element-binding protein 2 via the helix-loop-helix-leucine zipper domain is a prerequisite for its nuclear localization mediated by importin β. Mol. Cell. Biol. 21, 2779–2789 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lee, S. J. et al. The structure of importin-beta bound to SREBP-2: nuclear import of a transcription factor. Science 302, 1571–1575 (2003).
  CAS PubMed Google Scholar
• Hirano, Y., Yoshida, M., Shimizu, M. & Sato, R. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin–proteasome pathway. J. Biol. Chem. 276, 36431–36437 (2001).
  CAS PubMed Google Scholar
• Punga, T., Bengoechea-Alonso, M. T. & Ericsson, J. Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-1 in response to DNA binding. J. Biol. Chem. 281, 25278–25286 (2006).
  CAS PubMed Google Scholar
• Sundqvist, A. et al. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF (Fbw7). Cell Metab. 1, 379–391 (2005).
  CAS PubMed Google Scholar
• Giandomenico, V., Simonsson, M., Gronroos, E. & Ericsson, J. Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol. Cell. Biol. 23, 2587–2599 (2003).
  CAS PubMed PubMed Central Google Scholar
• Sundqvist, A. & Ericsson, J. Transcription-dependent degradation controls the stability of the SREBP family of transcription factors. Proc. Natl Acad. Sci. USA 100, 13833–13838 (2003).
  CAS PubMed PubMed Central Google Scholar
• Dong, Q. et al. Glycogen synthase kinase-3-mediated phosphorylation of serine 73 targets sterol response element binding protein-1c (SREBP-1c) for proteasomal degradation. Biosci. Rep. 36, e00284 (2016).
  PubMed Central Google Scholar
• Xiong, S., Chirala, S. S. & Wakil, S. J. Sterol regulation of human fatty acid synthase promoter I requires nuclear factor-Y- and Sp-1-binding sites. Proc. Natl Acad. Sci. USA 97, 3948–3953 (2000).
  CAS PubMed PubMed Central Google Scholar
• Inoue, J., Sato, R. & Maeda, M. Multiple DNA elements for sterol regulatory element-binding protein and NF-Y are responsible for sterol-regulated transcription of the genes for human 3-hydroxy-3-methylglutaryl coenzyme A synthase and squalene synthase. J. Biochem. 123, 1191–1198 (1998).
  CAS PubMed Google Scholar
• Misawa, K. et al. Sterol regulatory element-binding protein-2 interacts with hepatocyte nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes. J. Biol. Chem. 278, 36176–36182 (2003).
  CAS PubMed Google Scholar
• Kanayama, T. et al. Interaction between sterol regulatory element-binding proteins and liver receptor homolog-1 reciprocally suppresses their transcriptional activities. J. Biol. Chem. 282, 10290–10298 (2007).
  CAS PubMed Google Scholar
• Louet, J. F., Hayhurst, G., Gonzalez, F. J., Girard, J. & Decaux, J. F. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 α and cAMP-response element-binding protein (CREB). J. Biol. Chem. 277, 37991–38000 (2002).
  CAS PubMed Google Scholar
• Yamamoto, T. et al. SREBP-1 interacts with hepatocyte nuclear factor-4α and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J. Biol. Chem. 279, 12027–12035 (2004).
  CAS PubMed Google Scholar
• Ponugoti, B., Fang, S. & Kemper, J. K. Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-γ coactivator 1α in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c. Mol. Endocrinol. 21, 2698–2712 (2007).
  CAS PubMed Google Scholar
• Lin, J. et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP. Cell 120, 261–273 (2005).
  CAS PubMed Google Scholar
• Zeng, L. et al. ATF6 modulates SREBP2-mediated lipogenesis. EMBO J. 23, 950–958 (2004).
  CAS PubMed PubMed Central Google Scholar
• Amemiya-Kudo, M. et al. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J. Biol. Chem. 275, 31078–31085 (2000).
  CAS PubMed Google Scholar
• Repa, J. J. et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14, 2819–2830 (2000).
  CAS PubMed PubMed Central Google Scholar
• Yoshikawa, T. et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 21, 2991–3000 (2001).
  CAS PubMed PubMed Central Google Scholar
• Okazaki, H., Goldstein, J. L., Brown, M. S. & Liang, G. LXR–SREBP-1c–phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size. J. Biol. Chem. 285, 6801–6810 (2010).
  CAS PubMed Google Scholar
• Schultz, J. R. et al. Role of LXRs in control of lipogenesis. Genes Dev. 14, 2831–2838 (2000).
  CAS PubMed PubMed Central Google Scholar
• Kim, G. H. et al. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor. J. Clin. Invest. 125, 183–193 (2015).
  PubMed Google Scholar
• Takeuchi, Y. et al. KLF15 enables rapid switching between lipogenesis and gluconeogenesis during fasting. Cell Rep. 16, 2373–2386 (2016).
  CAS PubMed PubMed Central Google Scholar
• Chen, G., Liang, G., Ou, J., Goldstein, J. L. & Brown, M. S. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl Acad. Sci. USA 101, 11245–11250 (2004).
  CAS PubMed PubMed Central Google Scholar
• Bindesboll, C. et al. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity. J. Lipid Res. 56, 771–785 (2015).
  PubMed PubMed Central Google Scholar
• Tian, J., Goldstein, J. L. & Brown, M. S. Insulin induction of SREBP-1c in rodent liver requires LXRα–C/EBPβ complex. Proc. Natl Acad. Sci. USA 113, 8182–8187 (2016).
  CAS PubMed PubMed Central Google Scholar
• Wang, G. X. et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat. Med. 20, 1436–1443 (2014).
  CAS PubMed PubMed Central Google Scholar
• Shimomura, I. et al. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl Acad. Sci. USA 96, 13656–13661 (1999).
  CAS PubMed PubMed Central Google Scholar
• Wang, Y., Viscarra, J., Kim, S. J. & Sul, H. S. Transcriptional regulation of hepatic lipogenesis. Nat. Rev. Mol. Cell Biol. 16, 678–689 (2015).
  CAS PubMed PubMed Central Google Scholar
• Krycer, J. R., Sharpe, L. J., Luu, W. & Brown, A. J. The Akt–SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol. Metab. 21, 268–276 (2010).
  CAS PubMed Google Scholar
• Howell, J. J., Ricoult, S. J., Ben-Sahra, I. & Manning, B. D. A growing role for mTOR in promoting anabolic metabolism. Biochem. Soc. Trans. 41, 906–912 (2013).
  CAS PubMed Google Scholar
• Zoncu, R., Efeyan, A. & Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21–35 (2011).
  CAS PubMed Google Scholar
• Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224–236 (2008).
  CAS PubMed PubMed Central Google Scholar
• Hagiwara, A. et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15, 725–738 (2012).
  CAS PubMed Google Scholar
• Yecies, J. L. et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14, 21–32 (2011).
  CAS PubMed PubMed Central Google Scholar
• Peterson, T. R. et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408–420 (2011).
  CAS PubMed PubMed Central Google Scholar
• Han, J. et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature 524, 243–246 (2015).
  CAS PubMed Google Scholar
• Duvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171–183 (2010).
  PubMed PubMed Central Google Scholar
• Brown, M. S. & Goldstein, J. L. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 95–96 (2008).
  CAS PubMed Google Scholar
• Leavens, K. F., Easton, R. M., Shulman, G. I., Previs, S. F. & Birnbaum, M. J. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 10, 405–418 (2009).
  CAS PubMed PubMed Central Google Scholar
• Biddinger, S. B. et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 7, 125–134 (2008).
  CAS PubMed PubMed Central Google Scholar
• Li, S., Brown, M. S. & Goldstein, J. L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl Acad. Sci. USA 107, 3441–3446 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ai, D. et al. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. J. Clin. Invest. 122, 1677–1687 (2012).
  CAS PubMed PubMed Central Google Scholar
• Owen, J. L. et al. Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase. Proc. Natl Acad. Sci. USA 109, 16184–16189 (2012).
  CAS PubMed PubMed Central Google Scholar
• Khamzina, L., Veilleux, A., Bergeron, S. & Marette, A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146, 1473–1481 (2005).
  CAS PubMed Google Scholar
• Tzatsos, A. & Kandror, K. V. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol. Cell. Biol. 26, 63–76 (2006).
  CAS PubMed PubMed Central Google Scholar
• Tremblay, F. et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl Acad. Sci. USA 104, 14056–14061 (2007).
  CAS PubMed PubMed Central Google Scholar
• Hsu, P. P. et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317–1322 (2011).
  CAS PubMed PubMed Central Google Scholar
• Huang, J., Dibble, C. C., Matsuzaki, M. & Manning, B. D. The TSC1–TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 28, 4104–4115 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yuan, M., Pino, E., Wu, L., Kacergis, M. & Soukas, A. A. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J. Biol. Chem. 287, 29579–29588 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wan, M. et al. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab. 14, 516–527 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kenerson, H. L., Subramanian, S., McIntyre, R., Kazami, M. & Yeung, R. S. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. PLoS ONE 10, e0117000 (2015).
  PubMed PubMed Central Google Scholar
• Jump, D. B., Tripathy, S. & Depner, C. M. Fatty acid-regulated transcription factors in the liver. Annu. Rev. Nutr. 33, 249–269 (2013).
  CAS PubMed PubMed Central Google Scholar
• Tripathy, S. & Jump, D. B. Elovl5 regulates the mTORC2–Akt–FOXO1 pathway by controlling hepatic _cis_-vaccenic acid synthesis in diet-induced obese mice. J. Lipid Res. 54, 71–84 (2013).
  CAS PubMed PubMed Central Google Scholar
• Tong, X. et al. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis. J. Lipid Res. 57, 1219–1230 (2016).
  CAS PubMed PubMed Central Google Scholar
• Ide, T. et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat. Cell Biol. 6, 351–357 (2004).
  CAS PubMed Google Scholar
• Kubota, N. et al. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nat. Commun. 7, 12977 (2016).
  CAS PubMed PubMed Central Google Scholar
• Matsuzaka, T. et al. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 53, 560–569 (2004).
  CAS PubMed Google Scholar
• Haas, J. T. et al. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab. 15, 873–884 (2012).
  CAS PubMed PubMed Central Google Scholar
• Samuel, V. T. & Shulman, G. I. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J. Clin. Invest. 126, 12–22 (2016).
  PubMed PubMed Central Google Scholar
• Matsumoto, M. et al. PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest. 112, 935–944 (2003).
  CAS PubMed PubMed Central Google Scholar
• Taniguchi, C. M. et al. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKCλ/ζ. Cell Metab. 3, 343–353 (2006).
  CAS PubMed Google Scholar
• Yamamoto, T. et al. Protein kinase Cβ mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin. J. Lipid Res. 51, 1859–1870 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ueki, K., Kondo, T., Tseng, Y. H. & Kahn, C. R. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl Acad. Sci. USA 101, 10422–10427 (2004).
  CAS PubMed PubMed Central Google Scholar
• Sajan, M. P. et al. The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFκB in obesity. J. Lipid Res. 50, 1133–1145 (2009).
  CAS PubMed PubMed Central Google Scholar
• Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376–388 (2011).
  CAS PubMed PubMed Central Google Scholar
• Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577–590 (2003).
  CAS PubMed Google Scholar
• Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214–226 (2008).
  CAS PubMed PubMed Central Google Scholar
• Lu, M. & Shyy, J. Y. Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am. J. Physiol. Cell Physiol. 290, C1477–C1486 (2006).
  CAS PubMed Google Scholar
• Yamamoto, T. et al. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J. Biol. Chem. 282, 11687–11695 (2007).
  CAS PubMed Google Scholar
• Dong, Q. et al. Phosphorylation of sterol regulatory element binding protein-1a by protein kinase A (PKA) regulates transcriptional activity. Biochem. Biophys. Res. Commun. 449, 449–454 (2014).
  CAS PubMed PubMed Central Google Scholar
• Defour, A. et al. Sirtuin 1 regulates SREBP-1c expression in a LXR-dependent manner in skeletal muscle. PLoS ONE 7, e43490 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ponugoti, B. et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 285, 33959–33970 (2010).
  CAS PubMed PubMed Central Google Scholar
• Jin, S. H. et al. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. Toxicol. Appl. Pharmacol. 271, 95–105 (2013).
  CAS PubMed Google Scholar
• Worgall, T. S., Sturley, S. L., Seo, T., Osborne, T. F. & Deckelbaum, R. J. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem. 273, 25537–25540 (1998).
  CAS PubMed Google Scholar
• Yahagi, N. et al. A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J. Biol. Chem. 274, 35840–35844 (1999).
  CAS PubMed Google Scholar
• Jump, D. B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13, 155–164 (2002).
  CAS PubMed Google Scholar
• Takeuchi, Y. et al. Polyunsaturated fatty acids selectively suppress sterol regulatory element-binding protein-1 through proteolytic processing and autoloop regulatory circuit. J. Biol. Chem. 285, 11681–11691 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kim, J. et al. Identification of Rbd2 as a candidate protease for sterol regulatory element binding protein (SREBP) cleavage in fission yeast. Biochem. Biophys. Res. Commun. 468, 606–610 (2015).
  CAS PubMed Google Scholar
• Hwang, J. et al. A Golgi rhomboid protease Rbd2 recruits Cdc48 to cleave yeast SREBP. EMBO J. 35, 2332–2349 (2016).
  CAS PubMed PubMed Central Google Scholar
• Guo, F. & Cavener, D. R. The GCN2 eIF2α kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab. 5, 103–114 (2007).
  CAS PubMed Google Scholar
• Broer, S. & Broer, A. Amino acid homeostasis and signalling in mammalian cells and organisms. Biochem. J. 474, 1935–1963 (2017).
  CAS PubMed Google Scholar
• Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763–777 (2007).
  CAS PubMed Google Scholar
• Guo, D., Bell, E. H., Mischel, P. & Chakravarti, A. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr. Pharm. Des. 20, 2619–2626 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ricoult, S. J., Yecies, J. L., Ben-Sahra, I. & Manning, B. D. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP. Oncogene 35, 1250–1260 (2016).
  CAS PubMed Google Scholar
• Freed-Pastor, W. A. et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148, 244–258 (2012).
  CAS PubMed PubMed Central Google Scholar
• Teresi, R. E., Planchon, S. M., Waite, K. A. & Eng, C. Regulation of the PTEN promoter by statins and SREBP. Hum. Mol. Genet. 17, 919–928 (2008).
  CAS PubMed Google Scholar
• Inoue, J. et al. Glutamine stimulates the gene expression and processing of sterol regulatory element binding proteins, thereby increasing the expression of their target genes. FEBS J. 278, 2739–2750 (2011).
  CAS PubMed Google Scholar
• Guo, D. et al. EGFR signaling through an Akt–SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci. Signal. 2, ra82 (2009).
  PubMed PubMed Central Google Scholar
• Haskins, J. W. et al. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake. Sci. Signal. 8, ra111 (2015).
  PubMed PubMed Central Google Scholar
• Cheng, C. et al. Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth. Cancer Cell 28, 569–581 (2015).
  CAS PubMed PubMed Central Google Scholar
• Yamauchi, Y., Furukawa, K., Hamamura, K. & Furukawa, K. Positive feedback loop between PI3K–Akt–mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen. Cancer Res. 71, 4989–4997 (2011).
  CAS PubMed Google Scholar
• Torres-Ayuso, P., Tello-Lafoz, M., Merida, I. & Avila-Flores, A. Diacylglycerol kinase-ζ regulates mTORC1 and lipogenic metabolism in cancer cells through SREBP-1. Oncogenesis 4, e164 (2015).
  CAS PubMed PubMed Central Google Scholar
• Zahra Bathaie, S., Ashrafi, M., Azizian, M. & Tamanoi, F. Mevalonate pathway and human cancers. Curr. Mol. Pharmacol. 10, 77–85 (2017).
  Google Scholar
• Shamma, A. et al. Rb regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 15, 255–269 (2009).
  CAS PubMed Google Scholar
• Warburg, O. On the origin of cancer cells. Science 123, 309–314 (1956).
  CAS PubMed Google Scholar
• Gao, P. et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762–765 (2009).
  CAS PubMed PubMed Central Google Scholar
• Xiao, D. et al. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2. Oncotarget 6, 40655–40666 (2015).
  PubMed PubMed Central Google Scholar
• Ricoult, S. J., Dibble, C. C., Asara, J. M. & Manning, B. D. SREBP regulates the expression and metabolic functions of wild-type and oncogenic IDH1. Mol. Cell. Biol. 36, 2384–2395 (2016).
  CAS PubMed PubMed Central Google Scholar
• Dasgupta, S. et al. Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis. J. Clin. Invest. 125, 1174–1188 (2015).
  PubMed PubMed Central Google Scholar
• Liu, L. et al. Arginine methylation of SREBP1a via PRMT5 promotes de novo lipogenesis and tumor growth. Cancer Res. 76, 1260–1272 (2016).
  CAS PubMed Google Scholar
• Kamisuki, S. et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem. Biol. 16, 882–892 (2009).
  CAS PubMed Google Scholar
• Tang, J. J. et al. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab. 13, 44–56 (2011).
  CAS PubMed Google Scholar
• Nakakuki, M. et al. A transcription factor of lipid synthesis, sterol regulatory element-binding protein (SREBP)-1a causes G1 cell-cycle arrest after accumulation of cyclin-dependent kinase (cdk) inhibitors. FEBS J. 274, 4440–4452 (2007).
  CAS PubMed Google Scholar
• Inoue, N. et al. Lipid synthetic transcription factor SREBP-1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor. Mol. Cell. Biol. 25, 8938–8947 (2005).
  CAS PubMed PubMed Central Google Scholar
• Bengoechea-Alonso, M. T. & Ericsson, J. The phosphorylation-dependent regulation of nuclear SREBP1 during mitosis links lipid metabolism and cell growth. Cell Cycle 15, 2753–2765 (2016).
  CAS PubMed PubMed Central Google Scholar
• Griffiths, B. et al. Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Cancer Metab. 1, 3 (2013).
  PubMed PubMed Central Google Scholar
• Beloribi-Djefaflia, S., Vasseur, S. & Guillaumond, F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 5, e189 (2016).
  CAS PubMed PubMed Central Google Scholar
• Williams, K. J. et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Res. 73, 2850–2862 (2013).
  CAS PubMed PubMed Central Google Scholar
• Muranaka, H. et al. A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling. Oncogenesis 6, e350 (2017).
  CAS PubMed PubMed Central Google Scholar
• Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900–917 (2010).
  CAS PubMed PubMed Central Google Scholar
• Rohrl, C. et al. Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells. J. Lipid Res. 55, 94–103 (2014).
  PubMed PubMed Central Google Scholar
• Lee, J. S. et al. Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model. Toxicol. Lett. 211, 29–38 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lee, J. N. & Ye, J. Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J. Biol. Chem. 279, 45257–45265 (2004).
  CAS PubMed Google Scholar
• Lauressergues, E. et al. Does endoplasmic reticulum stress participate in APD-induced hepatic metabolic dysregulation? Neuropharmacology 62, 784–796 (2012).
  CAS PubMed Google Scholar
• Kammoun, H. L. et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201–1215 (2009).
  CAS PubMed PubMed Central Google Scholar
• Li, H. et al. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response. Biochim. Biophys. Acta 1842, 1844–1854 (2014).
  CAS PubMed PubMed Central Google Scholar
• Fang, S. et al. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 98, 14422–14427 (2001).
  CAS PubMed PubMed Central Google Scholar
• Zhang, T. et al. Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer. PLoS ONE 10, e0118448 (2015).
  PubMed PubMed Central Google Scholar
• Wang, J. et al. n-3 polyunsaturated fatty acids protect against pancreatic β-cell damage due to ER stress and prevent diabetes development. Mol. Nutr. Food Res. 59, 1791–1802 (2015).
  CAS PubMed Google Scholar
• Sanchez-Alvarez, M. et al. Signaling networks converge on TORC1–SREBP activity to promote endoplasmic reticulum homeostasis. PLoS ONE 9, e101164 (2014).
  PubMed PubMed Central Google Scholar
• Appenzeller-Herzog, C. & Hall, M. N. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 22, 274–282 (2012).
  CAS PubMed Google Scholar
• Seo, Y. K. et al. Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif. Proc. Natl Acad. Sci. USA 106, 13765–13769 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15, 1012–1020 (1996).
  CAS PubMed PubMed Central Google Scholar
• Im, S. S. & Osborne, T. F. Protection from bacterial-toxin-induced apoptosis in macrophages requires the lipogenic transcription factor sterol regulatory element binding protein 1a. Mol. Cell. Biol. 32, 2196–2202 (2012).
  CAS PubMed PubMed Central Google Scholar
• Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397–411 (2013).
  CAS PubMed Google Scholar
• Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821–832 (2010).
  CAS PubMed Google Scholar
• Karasawa, T. et al. Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 1788–1795 (2011).
  CAS PubMed Google Scholar
• Lei, X. et al. Evidence of contribution of iPLA2β-mediated events during islet β-cell apoptosis due to proinflammatory cytokines suggests a role for iPLA2β in T1D development. Endocrinology 155, 3352–3364 (2014).
  PubMed PubMed Central Google Scholar
• Chew, W. S. & Ong, W. Y. Regulation of calcium-independent phospholipase A2 expression by adrenoceptors and sterol regulatory element binding protein-potential crosstalk between sterol and glycerophospholipid mediators. Mol. Neurobiol. 53, 500–517 (2016).
  CAS PubMed Google Scholar
• Guan, M. et al. Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6. Clin. Cancer Res. 17, 1796–1806 (2011).
  CAS PubMed Google Scholar
• O'Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553–565 (2016).
  CAS PubMed PubMed Central Google Scholar
• van Kempen, T. S., Wenink, M. H., Leijten, E. F., Radstake, T. R. & Boes, M. Perception of self: distinguishing autoimmunity from autoinflammation. Nat. Rev. Rheumatol. 11, 483–492 (2015).
  CAS PubMed Google Scholar
• Oishi, Y. et al. SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism. Cell Metab. 25, 412–427 (2017).
  CAS PubMed Google Scholar
• Gilardi, F. et al. Genome-wide analysis of SREBP1 activity around the clock reveals its combined dependency on nutrient and circadian signals. PLoS Genet. 10, e1004155 (2014).
  PubMed PubMed Central Google Scholar
• Eckel-Mahan, K. L. et al. Reprogramming of the circadian clock by nutritional challenge. Cell 155, 1464–1478 (2013).
  CAS PubMed PubMed Central Google Scholar
• Matsumoto, E. et al. Time of day and nutrients in feeding govern daily expression rhythms of the gene for sterol regulatory element-binding protein (SREBP)-1 in the mouse liver. J. Biol. Chem. 285, 33028–33036 (2010).
  CAS PubMed PubMed Central Google Scholar
• Masri, S. et al. Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 158, 659–672 (2014).
  CAS PubMed PubMed Central Google Scholar
• Tao, R., Xiong, X., DePinho, R. A., Deng, C. X. & Dong, X. C. Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. J. Lipid Res. 54, 2745–2753 (2013).
  CAS PubMed PubMed Central Google Scholar
• Le Martelot, G. et al. REV-ERBα participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol. 7, e1000181 (2009).
  PubMed PubMed Central Google Scholar
• Cretenet, G., Le Clech, M. & Gachon, F. Circadian clock-coordinated 12 Hr period rhythmic activation of the IRE1α pathway controls lipid metabolism in mouse liver. Cell Metab. 11, 47–57 (2010).
  CAS PubMed Google Scholar
• Masri, S. et al. Lung adenocarcinoma distally rewires hepatic circadian homeostasis. Cell 165, 896–909 (2016).
  CAS PubMed PubMed Central Google Scholar
• Etchegaray, J. P. et al. Casein kinase 1δ regulates the pace of the mammalian circadian clock. Mol. Cell. Biol. 29, 3853–3866 (2009).
  CAS PubMed PubMed Central Google Scholar
• Brookheart, R. T., Lee, C. Y. & Espenshade, P. J. Casein kinase 1 regulates sterol regulatory element-binding protein (SREBP) to control sterol homeostasis. J. Biol. Chem. 289, 2725–2735 (2014).
  CAS PubMed Google Scholar
• Horton, J. D., Bashmakov, Y., Shimomura, I. & Shimano, H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl Acad. Sci. USA 95, 5987–5992 (1998).
  CAS PubMed PubMed Central Google Scholar
• Shimano, H. et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 274, 35832–35839 (1999).
  CAS PubMed Google Scholar
• Yahagi, N. et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep ob /Lep ob mice. J. Biol. Chem. 277, 19353–19357 (2002).
  CAS PubMed Google Scholar
• Moon, Y. A. et al. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 15, 240–246 (2012).
  CAS PubMed PubMed Central Google Scholar
• Liu, J. Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver. World J. Gastroenterol. 20, 14672–14685 (2014).
  CAS PubMed PubMed Central Google Scholar
• Osei-Hyiaman, D. et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J. Clin. Invest. 118, 3160–3169 (2008).
  CAS PubMed PubMed Central Google Scholar
• Bose, S. K. et al. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. J. Virol. 88, 4195–4203 (2014).
  PubMed PubMed Central Google Scholar
• McRae, S. et al. The hepatitis C virus-induced NLRP3 inflammasome activates the sterol regulatory element-binding protein (SREBP) and regulates lipid metabolism. J. Biol. Chem. 291, 3254–3267 (2016).
  CAS PubMed Google Scholar
• Pajvani, U. B. et al. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat. Med. 19, 1054–1060 (2013).
  CAS PubMed PubMed Central Google Scholar
• Lee, Y. H. et al. Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK. Int. J. Obes. (Lond.) 40, 356–365 (2016).
  CAS Google Scholar
• Nagaya, T. et al. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J. Hepatol. 53, 724–731 (2010).
  CAS PubMed Google Scholar
• Zhang, W. et al. Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells. Int. J. Biochem. Cell Biol. 45, 736–744 (2013).
  CAS PubMed Google Scholar
• Zhai, X. et al. The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis. Br. J. Pharmacol. 169, 197–212 (2013).
  CAS PubMed PubMed Central Google Scholar
• Van Rooyen, D. M. et al. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 141, 1393–1403 (2011).
  CAS PubMed Google Scholar
• Tomita, K. et al. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice. Hepatology 59, 154–169 (2014).
  CAS PubMed Google Scholar
• Kang, Q. & Chen, A. Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1. Endocrinology 150, 5384–5394 (2009).
  CAS PubMed PubMed Central Google Scholar
• Siersbaek, R., Nielsen, R. & Mandrup, S. PPARγ in adipocyte differentiation and metabolism — novel insights from genome-wide studies. FEBS Lett. 584, 3242–3249 (2010).
  CAS PubMed Google Scholar
• Payne, V. A. et al. C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis. Biochem. J. 425, 215–223 (2010).
  CAS Google Scholar
• Kim, J. B., Wright, H. M., Wright, M. & Spiegelman, B. M. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc. Natl Acad. Sci. USA 95, 4333–4337 (1998).
  CAS PubMed PubMed Central Google Scholar
• Fajas, L. et al. Regulation of peroxisome proliferator-activated receptor γ expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol. Cell. Biol. 19, 5495–5503 (1999).
  CAS PubMed PubMed Central Google Scholar
• Shimano, H. et al. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J. Clin. Invest. 100, 2115–2124 (1997).
  CAS PubMed PubMed Central Google Scholar
• Sekiya, M. et al. SREBP-1-independent regulation of lipogenic gene expression in adipocytes. J. Lipid Res. 48, 1581–1591 (2007).
  CAS PubMed Google Scholar
• Shimomura, I. et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182–3194 (1998).
  CAS PubMed PubMed Central Google Scholar
• Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S. & Goldstein, J. L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401, 73–76 (1999).
  CAS PubMed Google Scholar
• Horton, J. D., Shimomura, I., Ikemoto, S., Bashmakov, Y. & Hammer, R. E. Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J. Biol. Chem. 278, 36652–36660 (2003).
  CAS PubMed Google Scholar
• Ayala-Sumuano, J. T. et al. Srebf1a is a key regulator of transcriptional control for adipogenesis. Sci. Rep. 1, 178 (2011).
  PubMed PubMed Central Google Scholar
• Fujii, N. et al. Sterol regulatory element-binding protein-1c orchestrates metabolic remodeling of white adipose tissue by caloric restriction. Aging Cell 16, 508–517 (2017).
  CAS PubMed PubMed Central Google Scholar
• Takahashi, A. et al. Transgenic mice overexpressing nuclear SREBP-1c in pancreatic β-cells. Diabetes 54, 492–499 (2005).
  CAS PubMed Google Scholar
• Ishikawa, M. et al. Cholesterol accumulation and diabetes in pancreatic β-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. J. Lipid Res. 49, 2524–2534 (2008).
  CAS PubMed Google Scholar
• Iwasaki, Y. et al. Nuclear SREBP-1a causes loss of pancreatic β-cells and impaired insulin secretion. Biochem. Biophys. Res. Commun. 378, 545–550 (2009).
  CAS PubMed Google Scholar
• Yamashita, T. et al. Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a β-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c. Endocrinology 145, 3566–3577 (2004).
  CAS PubMed Google Scholar
• Amemiya-Kudo, M. et al. Suppression of the pancreatic duodenal homeodomain transcription factor-1 (Pdx-1) promoter by sterol regulatory element-binding protein-1c (SREBP-1c). J. Biol. Chem. 286, 27902–27914 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kato, T. et al. Granuphilin is activated by SREBP-1c and involved in impaired insulin secretion in diabetic mice. Cell Metab. 4, 143–154 (2006).
  CAS PubMed Google Scholar
• Choi, S. E. et al. Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 β-cell death. Endocrinology 152, 816–827 (2011).
  CAS PubMed Google Scholar
• Xu, F. et al. SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. Diabetes 63, 3637–3646 (2014).
  CAS PubMed Google Scholar
• Ozbay, L. A. et al. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E β-cells. Br. J. Pharmacol. 162, 136–146 (2011).
  CAS PubMed PubMed Central Google Scholar
• Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 150, 1223–1234 (2012).
  CAS PubMed PubMed Central Google Scholar
• Shepardson, N. E., Shankar, G. M. & Selkoe, D. J. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch. Neurol. 68, 1385–1392 (2011).
  PubMed PubMed Central Google Scholar
• Shepardson, N. E., Shankar, G. M. & Selkoe, D. J. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch. Neurol. 68, 1239–1244 (2011).
  PubMed PubMed Central Google Scholar
• Barbero-Camps, E., Fernandez, A., Martinez, L., Fernandez-Checa, J. C. & Colell, A. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease. Hum. Mol. Genet. 22, 3460–3476 (2013).
  CAS PubMed PubMed Central Google Scholar
• Pierrot, N. et al. Amyloid precursor protein controls cholesterol turnover needed for neuronal activity. EMBO Mol. Med. 5, 608–625 (2013).
  CAS PubMed PubMed Central Google Scholar
• Suzuki, R., Ferris, H. A., Chee, M. J., Maratos-Flier, E. & Kahn, C. R. Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function. PLoS Biol. 11, e1001532 (2013).
  CAS PubMed PubMed Central Google Scholar
• Suzuki, R. et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 12, 567–579 (2010).
  CAS PubMed PubMed Central Google Scholar
• Valenza, M. et al. Disruption of astrocyte–neuron cholesterol cross talk affects neuronal function in Huntington's disease. Cell Death Differ. 22, 690–702 (2015).
  CAS PubMed Google Scholar
• Liu, L. et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell 160, 177–190 (2015).
  CAS PubMed PubMed Central Google Scholar
• Raeder, M. B., Ferno, J., Glambek, M., Stansberg, C. & Steen, V. M. Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci. Lett. 395, 185–190 (2006).
  CAS PubMed Google Scholar
• Raeder, M. B., Ferno, J., Vik-Mo, A. O. & Steen, V. M. SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Mol. Cell. Biochem. 289, 167–173 (2006).
  CAS PubMed Google Scholar
• Norrmen, C. et al. mTORC1 controls PNS myelination along the mTORC1–RXRγ–SREBP-lipid biosynthesis axis in Schwann cells. Cell Rep. 9, 646–660 (2014).
  CAS PubMed Google Scholar
• Preitschopf, A. et al. mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression. PLoS ONE 9, e107004 (2014).
  PubMed PubMed Central Google Scholar
• Le Hellard, S. et al. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Mol. Psychiatry 15, 463–472 (2010).
  CAS PubMed Google Scholar
• Steen, V. M. et al. Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment. Eur. Neuropsychopharmacol. 27, 589–598 (2016).
  PubMed Google Scholar
• Gnudi, L. Angiopoietins and diabetic nephropathy. Diabetologia 59, 1616–1620 (2016).
  CAS PubMed PubMed Central Google Scholar
• Proctor, G. et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55, 2502–2509 (2006).
  CAS PubMed Google Scholar
• Wang, Z. et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVB_db/db_ mice with type 2 diabetes. Diabetes 54, 2328–2335 (2005).
  CAS PubMed Google Scholar
• Ishigaki, N. et al. Involvement of glomerular SREBP-1c in diabetic nephropathy. Biochem. Biophys. Res. Commun. 364, 502–508 (2007).
  CAS PubMed Google Scholar
• Sun, L., Halaihel, N., Zhang, W., Rogers, T. & Levi, M. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J. Biol. Chem. 277, 18919–18927 (2002).
  CAS PubMed Google Scholar
• Chen, G. et al. SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells. J. Mol. Cell. Biol. 6, 516–530 (2014).
  CAS PubMed Google Scholar
• An, W. et al. Cyclin Y is involved in the regulation of adipogenesis and lipid production. PLoS ONE 10, e0132721 (2015).
  PubMed PubMed Central Google Scholar
• Sun, H., Yuan, Y. & Sun, Z. L. Cholesterol contributes to diabetic nephropathy through SCAP–SREBP-2 pathway. Int. J. Endocrinol. 2013, 592576 (2013).
  PubMed PubMed Central Google Scholar
• Godel, M. et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Invest. 121, 2197–2209 (2011).
  PubMed PubMed Central Google Scholar
• D'Agati, V. D. et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat. Rev. Nephrol. 12, 453–471 (2016).
  CAS PubMed Google Scholar
• Tominaga, T. et al. Transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids: implications in renal tubular ijury induced in obesity and diabetes. J. Biol. Chem. 291, 1348–1367 (2016).
  CAS PubMed Google Scholar
• Shao, W., Machamer, C. E. & Espenshade, P. J. Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner. J. Lipid Res. 57, 1564–1573 (2016).
  CAS PubMed PubMed Central Google Scholar
• Burr, R. et al. Mga2 transcription factor regulates an oxygen-responsive lipid homeostasis pathway in fission yeast. J. Biol. Chem. 291, 12171–12183 (2016).
  CAS PubMed PubMed Central Google Scholar
• Gholkar, A. A. et al. Fatostatin inhibits cancer cell proliferation by affecting mitotic microtubule spindle assembly and cell division. J. Biol. Chem. 291, 17001–17008 (2016).
  CAS PubMed PubMed Central Google Scholar
• Miyata, S., Inoue, J., Shimizu, M. & Sato, R. Xanthohumol improves diet-induced obesity and fatty liver by suppressing sterol regulatory element-binding protein (SREBP) activation. J. Biol. Chem. 290, 20565–20579 (2015).
  CAS PubMed PubMed Central Google Scholar
• Doddapattar, P. et al. Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in _ApoE_-deficient mice. Mol. Nutr. Food Res. 57, 1718–1728 (2013).
  CAS PubMed PubMed Central Google Scholar
• Aryal, B., Singh, A. K., Rotllan, N., Price, N. & Fernandez-Hernando, C. MicroRNAs and lipid metabolism. Curr. Opin. Lipidol. 28, 273–280 (2017).
  CAS PubMed PubMed Central Google Scholar
• Najafi-Shoushtari, S. H. et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566–1569 (2010).
  CAS PubMed Google Scholar
• Horie, T. et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl Acad. Sci. USA 107, 17321–17326 (2010).
  CAS PubMed PubMed Central Google Scholar
• Horie, T. et al. MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat. Commun. 4, 2883 (2013).
  PubMed Google Scholar
• Horie, T. et al. MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo. Sci. Rep 4, 5312 (2014).
  CAS PubMed PubMed Central Google Scholar
• Rottiers, V. & Naar, A. M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13, 239–250 (2012).
  CAS PubMed PubMed Central Google Scholar
• Karunakaran, D. et al. Therapeutic inhibition of miR-33 promotes fatty acid oxidation but does not ameliorate metabolic dysfunction in diet-induced obesity. Arterioscler. Thromb. Vasc. Biol. 35, 2536–2543 (2015).
  CAS PubMed PubMed Central Google Scholar
• Herrera-Merchan, A. et al. miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 9, 3277–3285 (2010).
  CAS PubMed Google Scholar
• Lin, Y. et al. MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci. Rep. 5, 9995 (2015).
  CAS PubMed PubMed Central Google Scholar
• Jeon, T. I. et al. An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab. 18, 51–61 (2013).
  CAS PubMed PubMed Central Google Scholar
• Yang, M. et al. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake. J. Lipid Res. 55, 226–238 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ru, P. et al. Feedback loop regulation of SCAP/SREBP-1 by miR-29 modulates EGFR signaling-driven glioblastoma growth. Cell Rep. 16, 1527–1535 (2016).
  CAS PubMed PubMed Central Google Scholar
• Everett, B. M., Smith, R. J. & Hiatt, W. R. Reducing LDL with PCSK9 inhibitors — the clinical benefit of lipid drugs. N. Engl. J. Med. 373, 1588–1591 (2015).
  PubMed Google Scholar
• Horton, J. D., Cohen, J. C. & Hobbs, H. H. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem. Sci. 32, 71–77 (2007).
  CAS PubMed PubMed Central Google Scholar
• Sabatine, M. S. et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N. Engl. J. Med. 372, 1500–1509 (2015).
  CAS PubMed Google Scholar
• Ma, K. L. et al. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Cardiovasc. Res. 100, 450–460 (2013).
  CAS PubMed Google Scholar
• Ai, D. et al. Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice. J. Clin. Invest. 122, 1262–1270 (2012).
  CAS PubMed PubMed Central Google Scholar
• Liu, J. et al. Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease. Int. J. Biochem. Cell Biol. 61, 8–19 (2015).
  CAS PubMed Google Scholar
• Ecker, J. et al. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc. Natl Acad. Sci. USA 107, 7817–7822 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wei, X. et al. Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature 539, 294–298 (2016).
  PubMed PubMed Central Google Scholar